Three Important Lessons from the FCPA Guidance for Pharmaceutical and Medical Device Companies

You may also like...

1 Response

  1. December 7, 2012

    […] Three lessons for medical device and pharma companies from DOJ’s Foreign Corrupt Practices Act guidelines (Corruption, Crime & Compliance) […]